SCHEMBL3105741

SCHEMBL3105741

CCSc1cc(C)c2cc(F)ccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.48
▸ HTT P42858 1/20 0.48
▸ MAPT P10636 5/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ POLB P06746 3/20 0.43
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ PRNP P04156 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.39
▸ HPGD P15428 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MPO P05164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3099980 0.88 TSHR (0.46) GAAHTTMAPTKDM4EPOLB
SCHEMBL12804121 0.84 GAA (0.65) GAAHTTMAPTKDM4EPOLB
SCHEMBL3111650 0.79 POLB (0.71) GAAHTTMAPTKDM4EPOLB
SCHEMBL29588228 0.74 CYP1A2 (0.57) GAAKDM4EPOLBALDH1A1CYP1A2
SCHEMBL6490334 0.74 CYP1A2 (0.57) GAAKDM4EPOLBALDH1A1CYP1A2
SCHEMBL12803452 0.74 GAA (0.50) GAAHTTMAPTKDM4EPOLB
SCHEMBL2534941 0.71 KDM4E (0.62) MAPTKDM4ECYP2C19ALDH1A1CYP3A4
SCHEMBL3101342 0.71 ELANE (0.43) HTTMAPTKDM4ECYP2C9CYP2C19
SCHEMBL3093630 0.71 RXFP1 (0.49) GAAHTTMAPTKDM4EPOLB
SCHEMBL3098810 0.70 L3MBTL1 (0.71) MAPTKDM4EPOLBCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399673-B2 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators GRUENENTHAL GMBH (DE) 2013-03-19 — — US disclosed
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators DRUNENTHAL GMBH (DE) 2012-10-04 — — US disclosed
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS GRUNENTHAL GMBH (DE) 2010-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234372-A1 SUBSTITUTED 2-MERCAPTOQUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS KCNQ1, KCNQ2, KCNJ2 GAA 4052/4885HTT 3508/4885MAPT 4434/4885
US-20120252841-A1 Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators KCNQ1, KCNQ2, KCNJ2 GAA 4052/4885HTT 3508/4885MAPT 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback